Position in AKBA
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$127,401
+$111,150 QoQ
Shares Held
111,756
+855.8% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 170 holders
Holding Since
Jun 2023
8 quarters on record
Voting authority
Sole 13%
Shared 0%
None 87%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MERCER GLOBAL ADVISORS INC /ADV holds $43,567,425 across 30 Drug Manufacturers - Specialty & Generic names. AKBA ranks #26 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
56,839 | $9,579,645 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
16,741 | $9,070,776 | |
| 3 | ZTS |
Zoetis Inc.
|
66,412 | $4,772,366 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
167,856 | $2,690,731 | |
| 5 | VTRS |
Viatris Inc
|
160,652 | $2,551,153 | |
| 6 | HLN |
Haleon plc
|
259,261 | $2,418,905 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
70,403 | $2,385,253 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
74,362 | $1,830,048 |
All Filings in AKBA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $127,401 | 111,756 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $16,251 | 11,692 | Shares | Sole | 2026-05-15 | |
| 2024-09-30 | $51,111 | 38,721 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $31,845 | 31,221 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $40,596 | 22,184 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $24,410 | 19,686 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $22,754 | 19,960 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $18,263 | 19,960 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||